AAAAAA
Results: 1-25/58
Authors:
VANKRAAIJ MGJ
DEKKER AW
PETERS E
FLUIT A
VERDONCK LF
ROZENBERGARSKA M
Citation: Mgj. Vankraaij et al., EMERGENCE AND INFECTIOUS COMPLICATIONS OF CIPROFLOXACIN-RESISTANT ESCHERICHIA-COLI IN HEMATOLOGICAL CANCER-PATIENTS, European journal of clinical microbiology & infectious diseases, 17(8), 1998, pp. 591-592
Authors:
BOS GMJ
VANPUTTEN WLJ
VANDERHOLT B
VANDENBENT M
VERDONCK LF
HAGENBEEK A
Citation: Gmj. Bos et al., FOR WHICH PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA IS PROPHYLAXIS FOR CENTRAL-NERVOUS-SYSTEM DISEASE MANDATORY, Annals of oncology, 9(2), 1998, pp. 191-194
Authors:
BELKACEMI Y
LABOPIN M
VERNANT JP
PRENTICE HG
TICHELLI A
SCHATTENBERG A
BOOGAERTS MA
ERNST P
DELLAVOLPE A
GOLDSTONE AH
JOUET JP
VERDONCK LF
LOCASCIULLI A
RIO B
OZSAHIN M
GORIN NC
Citation: Y. Belkacemi et al., CATARACTS AFTER TOTAL-BODY IRRADIATION AND BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE-LEUKEMIA IN COMPLETE REMISSION - A STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 41(3), 1998, pp. 659-668
Authors:
ELLERBROEK P
KUIPERS S
ROZENBERGARSKA M
VERDONCK LF
PETERSEN EJ
Citation: P. Ellerbroek et al., OERSKOVIA XANTHINEOLYTICA - A NEW PATHOGEN IN BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(5), 1998, pp. 503-505
Authors:
CORNELISSEN JJ
FIBBE WE
SCHATTENBERG AVMB
PETERSEN EJ
WILLEMZE R
DEWITTE TJM
LOWENBERG B
VERDONCK LF
VANDERBIEZEN A
BRAND R
Citation: Jj. Cornelissen et al., A RETROSPECTIVE DUTCH STUDY COMPARING T-CELL DEPLETED ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION VS T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 66-70
Authors:
CORNELISSEN JJ
LOWENBERG B
FIBBE W
WILLEMZE R
SCHATTENBERG A
DEWITTE T
PETERSEN E
VERDONCK LF
VANBIEZEN A
BRAND R
Citation: Jj. Cornelissen et al., ENHANCED INCIDENCE OF CHRONIC GVHD AND REDUCED RELAPSE RATE FOLLOWINGT-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS COMPARED TO T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 48-48
Authors:
LOKHORST HM
SONNEVELD P
CORNELISSEN JJ
CROOCKEWIT S
VANDERHOLT B
KOOY MV
VANOERS RHJ
RICHEL D
SEGEREN C
VELLENGA E
VERDONCK LF
VERHOEF G
WIJERMANS PW
Citation: Hm. Lokhorst et al., VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) INDUCTION THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II AND PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III STUDY, Bone marrow transplantation, 21, 1998, pp. 709-709
Authors:
VERDONCK LF
LOKHORST HM
ROOVERS DJ
VANHEUGTEN HG
Citation: Lf. Verdonck et al., MULTIDRUG-RESISTANT ACUTE-LEUKEMIA CELLS ARE RESPONSIVE TO PROLONGED EXPOSURE OF DAUNORUBICIN - IMPLICATIONS FOR LIPOSOME-ENCAPSULATED DAUNORUBICIN, Leukemia research, 22(3), 1998, pp. 249-256
Authors:
LOKHORST HM
SONNEVELD P
CORNELISSEN JJ
CROOCKEWIT S
VANDERHOLT B
KOOY MV
VANOERS RHJ
RICHEL D
SEGEREN C
VELLENGA E
VERDONCK LF
VERHOEF G
WIJERMANS PW
Citation: Hm. Lokhorst et al., VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) FOLLOWED BY STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II AND PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III STUDY, British Journal of Haematology, 102(1), 1998, pp. 6-7
Authors:
BOONEN GJJC
RIJKSEN G
VERDONCK LF
MEDEMA RH
Citation: Gjjc. Boonen et al., GROWTH-CONTROL IN NORMAL AND LEUKEMIC T-LYMPHOCYTES, British Journal of Haematology, 102(1), 1998, pp. 31-31
Authors:
DOORDUIJN JK
VANDERHOLT B
BREED WPM
VANDERHEM KG
VANIMHOFF GW
KRAMER MHH
KOOY MV
VANOERS MHJ
OSSENKOPPELE GJ
RICHEL DJ
ROOZENDAAL KJ
VANTVEER MB
VERDONCK LF
VERHOEF G
WIJERMANS PW
SONNEVELD P
Citation: Jk. Doorduijn et al., EFFICACY OF STANDARD CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH POOR-RISK NON-HODGKINS-LYMPHOMA (NHL), British Journal of Haematology, 102(1), 1998, pp. 149-149
Authors:
VERDONCK LF
BOSBOOMKALSBEEK EC
VANBLOKLAND WTM
TILANUS MGJ
DEWEGER RA
Citation: Lf. Verdonck et al., MICROSATELLITE ANALYSIS FOR DONOR AND RECIPIENT CHIMERISM AFTER BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 102(1), 1998, pp. 208-208
Authors:
VANDIJK AMC
KESSLER FL
VERDONCK LF
DEGAST GC
OTTEN HG
Citation: Amc. Vandijk et al., COMPARISON OF B7-1 VERSUS ANTI-CD28 ANTIBODY IN PROVIDING COSTIMULATION FOR PRIMARY T-CELLS, British Journal of Haematology, 102(1), 1998, pp. 213-213
Authors:
VANDIJK AMC
KESSLER FL
VERDONCK LF
DEGAST GC
OTTEN HG
Citation: Amc. Vandijk et al., SELECTIVE DEPLETION OF ALLOANTIGEN ACTIVATED T-CELLS, British Journal of Haematology, 102(1), 1998, pp. 288-288
Authors:
VANBESIEN K
SOBOCINSKI K
ROWLINGS PA
MURPHY SC
ARMITAGE JO
BISHOP MR
CHAEKAL OK
GALE RP
KLEIN JP
LAZARUS HM
MCCARTHY PL
RAEMAEKERS JMM
REIFFERS J
PHILLIPS GL
SCHATTENBERG AVMB
VERDONCK LF
VOSE JM
HOROWITZ MM
Citation: K. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA, Blood, 92(5), 1998, pp. 1832-1836
Authors:
LOWENBERG B
VANPUTTEN WLJ
FERRANT A
OSSENKOPPELE G
VELLENGA E
VERDONCK LF
GRATWOHL A
BOOGAERTS MA
Citation: B. Lowenberg et al., PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AS AN ALTERNATIVE TOAUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA, Stem cells, 15, 1997, pp. 177-180
Authors:
VERDONCK LF
DEKKER AW
ROZENBERGARSKA M
VANDENHOEK MR
Citation: Lf. Verdonck et al., A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS, Clinical infectious diseases, 24(5), 1997, pp. 901-907
Authors:
DEKKER AW
VANTVEER MB
SIZOO W
HAAK HL
VANDERLELIE J
OSSENKOPPELE G
HUIJGENS PC
SCHOUTEN HC
SONNEVELD P
WILLEMZE R
VERDONCK LF
VANPUTTEN WLJ
LOWENBERG B
Citation: Aw. Dekker et al., INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(2), 1997, pp. 476-482
Authors:
LOWENBERG B
BOOGAERTS MA
DAENEN SMGJ
VERHOEF GEG
HAGENBEEK A
VELLENGA E
OSSENKOPPELE GJ
HUIJGENS PC
VERDONCK LF
VANDERLELIE J
WIELENGA JJ
SCHOUTEN HC
GMUR J
GRATWOHL A
HESS U
FEY MF
VANPUTTEN WLJ
Citation: B. Lowenberg et al., VALUE OF DIFFERENT MODALITIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR APPLIED DURING OR AFTER INDUCTION THERAPY OF ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 15(12), 1997, pp. 3496-3506
Authors:
BELKACEMI Y
LABOPIN M
VERNANT JP
PRENTICE HG
TICHELLI A
DEWITTE T
BOOGAERTS MA
ERNST P
DELLAVOLPE A
GOLDSTONE AH
JOUET JP
VERDONCK LF
RIO B
LOCASCIULLI A
OZSAHIN M
GORIN NC
Citation: Y. Belkacemi et al., CATARACTS FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) CONDITIONED WITH TOTAL-BODY IRRADIATION (TBI) FOR ACUTE-LEUKEMIA (AL) IN COMPLETE REMISSION (CR) - A STUDY OF THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 175-175
Authors:
VERDONCK LF
VANHEUGTEN HG
Citation: Lf. Verdonck et Hg. Vanheugten, ETHER LIPIDS ARE EFFECTIVE CYTOTOXIC DRUGS AGAINST MULTIDRUG-RESISTANT ACUTE-LEUKEMIA CELLS AND CAN ACT BY THE INDUCTION OF APOPTOSIS, Leukemia research, 21(1), 1997, pp. 37-43
Authors:
VANDIJK AMC
OTTEN HG
VERVERS C
DEBOER M
VERDONCK LF
DEGAST GC
Citation: Amc. Vandijk et al., HUMAN KERATINOCYTES EXPRESSING HLA CLASS-II INDUCE SHORT-TERM ALLERGYTOWARD ALLOANTIGENS, Transplantation proceedings, 29(1-2), 1997, pp. 1027-1028
Authors:
BIESMA DH
VANDENTWEEL JG
VERDONCK LF
Citation: Dh. Biesma et al., IMMUNOSUPPRESSIVE THERAPY FOR HYPOPLASTIC MYELODYSPLASTIC SYNDROME, Cancer, 79(8), 1997, pp. 1548-1551
Authors:
VANOJIK H
BIESMA DH
FIJNHEER R
HENE RJ
LOKHORST KM
ROODA SJE
VERDONCK LF
Citation: H. Vanojik et al., CYCLOSPORINE FOR THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER AUTOLOGOUSBONE-MARROW TRANSPLANTATION, British Journal of Haematology, 96(3), 1997, pp. 641-643
Authors:
VANDIJK AM
DEGAST GC
KESSLER FL
VANLIER RAW
VERDONCK LF
OTTEN HG
Citation: Am. Vandijk et al., DETECTION OF PRIMARY T-CELL RESPONSES AGAINST HUMAN KERATINOCYTES - TOWARDS GVHD PREDICTION, Blood, 90(10), 1997, pp. 4193-4193